| 1 |
Ofloxacin Oral Suspension IP
|
Each 5ml Contains: -
Ofloxacin
In a flavoured base
Approved colour used
|
50 mg
q.s.
|
| 2 |
Ofloxacin Oral Suspension IP
|
Each 5ml Contains: -
Ofloxacin
In a flavoured base
Approved colour used
|
100 mg
q.s.
|
| 3 |
Paracetamol Oral Suspension IP
|
Each 5ml Contains: -
Paracetamol
In a flavoured base
Approved colour used
|
500 mg
q.s.
|
| 4 |
Paracetamol Paediatric Oral Suspension IP
|
Each 5ml Contains: -
Paracetamol
In a flavoured base
Approved colour used
|
125 mg
q.s.
|
| 5 |
Paracetamol Paediatric Oral Suspension IP
|
Each 5ml Contains: -
Paracetamol
In a flavoured base
Approved colour used
|
250 mg
q.s.
|
| 6 |
Paracetamol Paediatric Syrup IP
|
Each 5ml Contains: -
Paracetamol
In a flavoured syrupy base
Approved colour used
|
125 mg
q.s.
|
| 7 |
Azithromycin Oral Suspension IP
|
Each 5ml Contains: -
Azithromycin Dihydrate
Eq. to Anhydrous Azithromycin
In a flavoured Syrupy base
Approved colour used
|
40 mg
q.s.
|
| 8 |
Azithromycin Oral Suspension IP
|
Each 5ml Contains: -
Azithromycin Dihydrate
Eq. to Anhydrous Azithromycin
In a flavoured Syrupy base
Approved colour used
|
50 mg
q.s.
|
| 9 |
Azithromycin Oral Suspension IP
|
Each 5ml Contains: -
Azithromycin Dihydrate
Eq. to Anhydrous Azithromycin
In a flavoured Syrupy base
Approved colour used
|
200 mg
q.s.
|
| 10 |
Albendazole Oral Suspension IP
|
Each 5ml Contains: -
Albendazole
In a flavoured Syrupy base
Approved colour used
|
200 mg
q.s.
|
| 11 |
Cetirizine Hydrochloride Syrup IP
|
Each 5ml Contains: -
Cetirizine Hydrochloride
In a flavoured Syrupy base
Approved colour used
|
5 mg
|
| 12 |
Sodium Valproate Oral Solution IP
|
Each 5 ml contains:
Sodium Valproate
Excipients
Approved Colour used
|
200 mg
q.s.
|
| 13 |
Paracetamol Suspension IP
|
Each 5 ml contains:
Paracetamol
Flavoured vehicle base
Excipients
Approved Colour used
|
120 mg
q.s.
|
| 14 |
Levocetirizine Dihydrochloride Syrup
|
Each 5 ml contains:
Levocetirizine Dihydrochloride
Excipients
In a flavoured syrupy base
Approved Colour used
|
2.5 mg
q.s.
|
| 15 |
Ambroxol Hydrochloride, Levosalbutamol &
Guaiphenesin Syrup
|
Each 5 ml contains:
Ambroxol Hydrochloride Levosalbutamol Sulphate
Eq. to Levosalbutamol
Guaiphenesin
Excipients
In a flavoured syrupy base
Approved Colour used
|
15 mg
0.5 mg
50 mg
q.s.
|
| 16 |
Ambroxol Hydrochloride,
Levosalbutamol Sulphate & Guaiphenesin Syrup
|
Each 5 ml Contains:
Ambroxol Hydrochloride
Levosalbutamol Sulphate
Eq. to Levosalbutamol
Guaiphenesin
In flavoured Syrupy base
Approved colour used
|
30 mg
1 mg
50 mg
q.s.
|
| 17 |
Dextromethorphan Hydrobromide, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Syrup
|
Each 5 ml Contains:
Dextromethorphan Hydrobromide Chlorpheniramine Maleate Phenylephrine Hydrochloride
In a pleasantly flavoured Syrupy
Approved colour used
|
10 mg
2 mg
5 mg
q.s.
|
| 18 |
Ambroxol,
Terbutaline sulphate, Guaiphenesin & menthol syrup
|
Each 5 ml contains:
Ambroxol Hcl
Terbutaline Sulphate
Gauiphenesin
Menthol
In flavoured Syrupy base
Approved colour Used
|
15 mg
1.25 mg
50 mg
2.5 mg
q.s.
|
| 19 |
Zinc Gluconate Suspension
|
Each 5 ml contains:
Zinc Gluconate
Eq. to elemental Zinc
In a flavoured syrupy base
Approved Colour used
|
20 mg
q.s.
|
| 20 |
Deflazacort Oral Suspension
|
Each 5 ml of suspension contains:
Deflazacort
Excipients
Approved Colour used
|
6 mg
q.s.
|
| 21 |
Levodropropizine &
Chlorpheniramine Maleate Syrup
|
Each 5 ml contains:
Levodropropizine
Chlorpheniramine Maleate
In a flavoured syrupy base
Approved Colour used
|
30 mg
2 mg
q.s.
|
| 22 |
Ambroxol Hydrochloride, Terbutaline Sulphate,
Guaiphenesin & Menthol Syrup
|
Each 5 ml contains:
Ambroxol Hydrochloride
Terbutaline Sulphate
Guaiphenesin
Menthol
In a flavoured Palatable base.
Approved Colour used
|
15 mg
1.25 mg
50 mg
1 mg
q.s.
|
| 23 |
Povidone-Iodine Solution IP
|
Povidone-Iodine
(Available Iodine 0.5% w/v)
Purified Water
|
5% w/v
q.s.
|
| 24 |
Liquid Paraffin,
Milk of Magnesia &
Sodium Picosulphate
Suspension
|
Each 5 ml contains:
Liquid Paraffin
Milk of Magnesia
Sodium Picosulphate
Approved Colour used
|
1.25 ml
3.75 ml
3.33 mg
q.s.
|
| 25 |
Levocetirizine Dihydrochloride and Montelukast Sodium Syrup
|
Each 5 ml contains:
Levocetirizine Dihydrochloride
Montelukast Sodium
Eq. to Montelukast
In a flavoured syrupy base
Approved Colour used
|
2.5 mg
4 mg
q.s.
|
| 26 |
Cyproheptadine Hydrochloride & Tricholine Citrate in Sorbitol Solution Syrup
|
Each 5 ml contains:
Cyproheptadine Hydrochloride
(Anhydrous)
Tricholine Citrate
Sorbitol Solution (70%) base
(Non Crystallizing)
In a flavoured syrupy base
Approved Colour used
|
2 mg
275 mg
375 mg
q.s.
|
| 27 |
Vitamin B-Complex
with L-Lysine Syrup
|
Each 5 ml contains:
Pyridoxine Hydrochloride
Nicotinamide
Cyanocobalamin
L-Lysine Hydrochloride
Sorbitol Solution (70 %)
(Non crystallising)
Approved Colour used
Appropriate overages of vitamins are added to compensate for loss on storage.
|
0.75 mg
15 mg
2 mcg
37.5 mg
q.s.
|
| 28 |
Lactulose Solution IP
|
Each 15 ml contains:
Lactulose Concentrate
Eq. to Lactulose
Aqueous base
Approved Colour used
|
10 gm
q.s.
|
| 29 |
Dextromethorphan Hydrobromide,
Phenylephirine Hydrochloride and Chlorpheniramine Maleate Syrup
|
"Each 5ml contains:
Dextromethorphan Hydrobromide Phenylephirine Hydrochloride "
Chlorpheniramine Maleate
In flavoured syrupy base
Approved Colour used
|
15 mg
5 mg
2.5 mcg
q.s.
|
| 30 |
Cyproheptadine Syrup
IP
|
Each 5ml Contains:
Cyproheptadine Hydrochloride
(anhydrous)
In flavoured syrupy base
Approved Colour used
|
2 mg
q.s.
|
| 31 |
Paracetamol and Mefenamic Acid Syrup
|
Each 5ml Contains:
Paracetamol
Mefenamic Acid
In flavoured syrupy base
Approved Colour used
|
250 mg
100 mg
q.s.
|
| 32 |
Chloramphenicol Palmitate Oral Suspension IP
|
Each 5ml Contains:
Chloramphenicol Palmitate
Eq. to Chloramphenicol
In flavoured syrupy base
Approved Colour used
|
125 mg
q.s
|
| 33 |
Promethazine Syrup IP
|
Each 5ml (one teaspoonful) Contains:
Promethazine Hydrochloride
In flavoured syrupy base
Approved Colour used
|
5 mg
q.s.
|
| 34 |
Ondansetron Oral Solution IP
|
Each 5ml contains:
Ondansetron Hydrochloride
Eq. to Ondansetron
In a flavoured syrupy base
Approved Colour used
|
2 mg
q.s.
|
| 35 |
Ranitidine Oral Solution IP
|
Each 5ml contains:
Ranitidine Hydrochloride
Eq. to Ranitidine
In a flavoured syrupy base
Approved Colour used
|
75 mg
q.s.
|
| 36 |
Ibuprofen and Paracetamol Suspension
|
Each 5ml Contains:
Ibuprofen
Paracetamol
In flavoured syrupy base
Approved Colour used
|
100mg
162.5mg
q.s.
|
| 37 |
Sucralfate & Oxetacaine Oral Suspension
|
Each 10ml Contains:
Sucralfate
Oxetacaine
In palatable sorbitol base
Approved Colour used
|
1g
20mg
q.s.
|